Jun 25, 2015 03:41PM Roth Positive on Keryx (KERX) Following Addition of Auryxia to Two Medicare Part D Formularies

Mar 4, 2015 12:21PM Streetinsider.com's Hot Lunchtime Reads 3/4: (KERX) (MCD) (RAX) (NLSN)

Mar 4, 2015 11:20AM Peer-Review Publications Continue Supporting Auryxia DIfferentiation - Roth Capital (KERX)

Feb 27, 2015 10:36AM Roth Capital Trims PT on Keryx Biopharma (KERX) to $27; 'Blocking and Tacking' w/ Medicare to Ensure Auryxia Success

Feb 25, 2015 12:14PM Roth Tweaks Numbers on Auryxia Ahead of Keryx Pharna's (KERX) Q4 Report; Maintains 'Buy' Rating

Jan 22, 2015 06:41AM Keryx Biopharma (KERX) Prices 9.17M Common Offering at $12/Share

Jan 21, 2015 07:53PM Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock

Dec 23, 2014 02:16PM Keryx Biopharma's (KERX) U.S. Launch of AURYXIA Follows Robust Development Program; Roth Affirms 'Buy' Rating

Nov 18, 2014 06:59AM Roth Capital Comments on Keryx (KERX) Following KOL Panel; Affirms 'Buy' Rating

Nov 6, 2014 11:27AM Roth Capital Remains Positive on Keryx (KERX) Following Q3 Results, Update

Oct 13, 2014 08:41AM NCE Status Won't Matter for Keryx Biopharma (KERX) - Roth Capital

Sep 29, 2014 09:52AM Roth Maintains Keryx Biopharma (KERX) at Buy Following Initiation of Ferric Citrate Phase 2

Sep 8, 2014 07:55AM Roth Raises PT on Keryx Biophama (KERX) to $32 Following Ferric Citrate Approval

Sep 2, 2014 09:00AM Full FDA Approval of Keryx's (KERX) Zerenex Expected - Roth Capital

Aug 7, 2014 12:05PM Roth Maintains Keryx (KERX) at 'Buy' Following Q2 Results; Long-Term Study Data Still Looks Good

May 23, 2014 06:52AM Roth Keeps Keryx Biopharma (KERX) at 'Buy' on PDUFA Update; Extension Preferred to CRL

May 8, 2014 11:22AM Keryx (KERX) Volatility Could Increase on Zerenex PDUFA Date Delay, but Risk Negligible - Roth

Apr 24, 2014 10:28AM Zerenex Costs Savings, Differentiation Highlighted; PDUFA Date Still in Focus (KERX) - Roth Capital

Apr 2, 2014 08:45AM Roth Affirms Keryx (KERX) at 'Buy'; ESRD Overhang Removed

Mar 14, 2014 10:17AM Roth Keeps Keryx Biopharma (KERX) at Buy; Zerenex Potential Remains Strong

Jan 23, 2014 06:55AM Keryx Biopharma (KERX) Prices 6.9M Offering at $14.50/Share

Jan 21, 2014 09:33AM Roth Capital Boosts PT on Keryx Biopharma (KERX) to $30 Following Ferric Citrate Approval in Japan

Jan 16, 2014 07:30AM Keryx Biopharma (KERX) Well-Positioned for Zerenex Approval in 2014 - Roth Capital

Oct 17, 2013 02:16PM Notable 52-Week Highs and Lows of the Day 10/17: (PRKR) (KERX) (DHR) High; (AMRN) (UTEK) (IBM) Low

Oct 16, 2013 12:46PM Unusual 11 Mid-Day Movers 10/16: (GURE) (XNY) (GERN) Higher; (RVM) (PTSX) (SWK) Lower

Oct 16, 2013 12:27PM Streetinsider.com's Hot Lunchtime Reads 10/16: (TSLA) (KERX) (GOOG) (FSLR)

Oct 16, 2013 12:21PM Roth Capital Boosts PT on Keryx (KERX) to $24; Recommends Buying Into ASN Meeting

Jan 31, 2013 06:53AM Keryx Biopharma (KERX) Prices 8.23M Offering at $8.49/Share

Jan 29, 2013 10:50AM Keryx Biopharmaceuticals (KERX) Continues Monumental Run-Up; Analysts See Another 40% Upside

Jan 28, 2013 12:48PM Keryx Biopharmaceuticals (KERX) Gets Another 'Going to $15' Call

Jan 28, 2013 12:27PM Streetinsider.com's Hot Lunchtime Reads 01/28: (GM) (GRPN) (LVS) (KERX) (SODA)

Jan 28, 2013 11:27AM Roth Capital Doubles PT on Keryx (KERX); Sees Another 200% Upside

Sep 21, 2012 12:38PM Unusual 11 Mid-Day Movers 09/21: (HALO) (KERX) (SNSS) Higher; (PEIX) (BTH) (KBH) Lower

Sep 21, 2012 11:48AM Keryx Biopharma (KERX) Moves Higher on Volume (AEZS)

May 10, 2012 02:24PM Unusual 11 Mid-Day Movers 05/10: (ADY) (INSP) (RPRX) Higher; (SGI) (WFR) (ARX) Lower

May 10, 2012 11:20AM Notable Analyst Rating Changes 05/10: (TPX) (PRU) (KERX) Upgraded; (VRTX) (HGSI) (ORCL) Downgraded

May 10, 2012 11:09AM Morning Movers 05/10: (ADY) (INSP) (KERX) (CYTX) Higher; (SGI) (CDTI) (ARX) (WFR) Lower

May 10, 2012 08:44AM Roth Capital Upgrades Keryx Biopharmaceuticals (KERX) to Buy

Apr 2, 2012 10:39AM Roth Capital Downgrades Keryx Biopharmaceuticals (KERX) to Neutral

Feb 25, 2010 08:04AM Roth Capital Initiates Coverage Biotechnology and Drugs KERX & CLDX